Abstract
Cigarette smoking is a major preventable cause of morbidity and mortality. It is the major risk factor for chronic obstructive pulmonary disease in the developed world. Smoking is a chronic relapsing disease. Optimal treatment includes nonpharmacologic support, together with pharmacotherapy. All clinicians should be comfortable with the use of nicotine replacement therapy, bupropion, and varenicline. Second-line therapies can be used by those familiar with their use. Effective use of these medications requires their integration into an effective management plan, which is likely to be a long-term undertaking, involving several cycles of remission and relapse.
Original language | English (US) |
---|---|
Pages (from-to) | 165-176 |
Number of pages | 12 |
Journal | Clinics in Chest Medicine |
Volume | 35 |
Issue number | 1 |
DOIs | |
State | Published - Mar 2014 |
Keywords
- Cessation
- Pharmacotherapy
- Smoking
- Treatment
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine